APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologics Regulatory Affairs Outsourcing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biologics Regulatory Affairs Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

15 April 2026199 pages

Choose your research edition.

Industry ResearchBiologics Regulatory Affairs Outsourcing Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics Regulatory Affairs Outsourcing Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Biologics Regulatory Affairs Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics Regulatory Affairs Outsourcing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Biologics Regulatory Affairs Outsourcing Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Biologics Regulatory Affairs Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biologics Regulatory Affairs Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biologics Regulatory Affairs Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologics Regulatory Affairs Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biologics Regulatory Affairs Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biologics Regulatory Affairs Outsourcing include Lonza AG, Wuxi AppTec Inc., Thermo Fisher Scientific Inc., Eurofins Scientific SE, Freyr solutions, Catalent Inc., Piramal Group, AGC Biologics and ICON Plc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biologics Regulatory Affairs Outsourcing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biologics Regulatory Affairs Outsourcing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biologics Regulatory Affairs Outsourcing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biologics Regulatory Affairs Outsourcing market size, projected growth trends, production technologies, key applications, and end-use industries.

Biologics Regulatory Affairs Outsourcing Segment by Company

Lonza AG

Wuxi AppTec Inc.

Thermo Fisher Scientific Inc.

Eurofins Scientific SE

Freyr solutions

Catalent Inc.

Piramal Group

AGC Biologics

ICON Plc.

Charles River Laboratories International, Inc.

Labcorp

Parexel International

Medpace Holdings, Inc.

IQVIA

Syneos Health

SGS SA (SGS)

Biologics Regulatory Affairs Outsourcing Segment by Type

Regulatory Consulting

Legal Representation

Regulatory Writing & Publishing

Product Registration

Regulatory Submissions

Regulatory Operations

Others

Biologics Regulatory Affairs Outsourcing Segment by Application

Monoclonal Antibodies (mAbs)

Recombinant Proteins

Vaccines

Cell & Gene Therapies

Biosimilars

Others

Biologics Regulatory Affairs Outsourcing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Regulatory Affairs Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics Regulatory Affairs Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Regulatory Affairs Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biologics Regulatory Affairs Outsourcing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biologics Regulatory Affairs Outsourcing industry.

Chapter 3: Detailed analysis of Biologics Regulatory Affairs Outsourcing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Regulatory Affairs Outsourcingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Regulatory Consulting Table 3. Key Players of Legal Representation Table 4. Key Players of Regulatory Writing & Publishing Table 3. Key Players of Product Registration Table 4. Key Players of Regulatory Submissions Table 5. Key Players of Regulatory Operations Table 6. Key Players of Others Table 7. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 8. Key Players of Monoclonal Antibodies (mAbs) Table 9. Key Players of Recombinant Proteins Table 10. Key Players of Vaccines Table 11. Key Players of Cell & Gene Therapies Table 12. Key Players of Biosimilars Table 13. Key Players of Others Table 14. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Biologics Regulatory Affairs Outsourcing Market Share by Region (2021-2026) Table 17. Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Biologics Regulatory Affairs Outsourcing Market Share by Region (2027-2032) Table 19. Biologics Regulatory Affairs Outsourcing Industry Trends Table 20. Biologics Regulatory Affairs Outsourcing Industry Drivers Table 21. Biologics Regulatory Affairs Outsourcing Industry Opportunities and Challenges Table 22. Biologics Regulatory Affairs Outsourcing Industry Restraints Table 23. Global Biologics Regulatory Affairs Outsourcing Revenue by Company (US$ Million) & (2021-2026) Table 24. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Company (2021-2026) Table 25. Global Biologics Regulatory Affairs Outsourcing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 26. Global Biologics Regulatory Affairs Outsourcing Key Company Head Office and Area Served Table 27. Global Biologics Regulatory Affairs Outsourcing Company, Product Type & Application Table 28. Global Biologics Regulatory Affairs Outsourcing Company Establishment Date Table 29. Global Company Market Concentration Ratio (CR5 and HHI) Table 30. Global Biologics Regulatory Affairs Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 31. Global Biologics Regulatory Affairs Outsourcing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 33. Global Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 34. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Type (2021-2026) Table 35. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Type (2027-2032) Table 36. Global Biologics Regulatory Affairs Outsourcing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 38. Global Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 39. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Application (2021-2026) Table 40. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Application (2027-2032) Table 41. Lonza AG Company Information Table 42. Lonza AG Business Overview Table 43. Lonza AG Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Lonza AG Biologics Regulatory Affairs Outsourcing Product Portfolio Table 45. Lonza AG Recent Development Table 46. Wuxi AppTec Inc. Company Information Table 47. Wuxi AppTec Inc. Business Overview Table 48. Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 50. Wuxi AppTec Inc. Recent Development Table 51. Thermo Fisher Scientific Inc. Company Information Table 52. Thermo Fisher Scientific Inc. Business Overview Table 53. Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 55. Thermo Fisher Scientific Inc. Recent Development Table 56. Eurofins Scientific SE Company Information Table 57. Eurofins Scientific SE Business Overview Table 58. Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Product Portfolio Table 60. Eurofins Scientific SE Recent Development Table 61. Freyr solutions Company Information Table 62. Freyr solutions Business Overview Table 63. Freyr solutions Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Freyr solutions Biologics Regulatory Affairs Outsourcing Product Portfolio Table 65. Freyr solutions Recent Development Table 66. Catalent Inc. Company Information Table 67. Catalent Inc. Business Overview Table 68. Catalent Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Catalent Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 70. Catalent Inc. Recent Development Table 71. Piramal Group Company Information Table 72. Piramal Group Business Overview Table 73. Piramal Group Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Piramal Group Biologics Regulatory Affairs Outsourcing Product Portfolio Table 75. Piramal Group Recent Development Table 76. AGC Biologics Company Information Table 77. AGC Biologics Business Overview Table 78. AGC Biologics Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. AGC Biologics Biologics Regulatory Affairs Outsourcing Product Portfolio Table 80. AGC Biologics Recent Development Table 81. ICON Plc. Company Information Table 82. ICON Plc. Business Overview Table 83. ICON Plc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. ICON Plc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 85. ICON Plc. Recent Development Table 86. Charles River Laboratories International, Inc. Company Information Table 87. Charles River Laboratories International, Inc. Business Overview Table 88. Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 90. Charles River Laboratories International, Inc. Recent Development Table 91. Labcorp Company Information Table 92. Labcorp Business Overview Table 93. Labcorp Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Labcorp Biologics Regulatory Affairs Outsourcing Product Portfolio Table 95. Labcorp Recent Development Table 96. Parexel International Company Information Table 97. Parexel International Business Overview Table 98. Parexel International Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Parexel International Biologics Regulatory Affairs Outsourcing Product Portfolio Table 100. Parexel International Recent Development Table 101. Medpace Holdings, Inc. Company Information Table 102. Medpace Holdings, Inc. Business Overview Table 103. Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 105. Medpace Holdings, Inc. Recent Development Table 106. IQVIA Company Information Table 107. IQVIA Business Overview Table 108. IQVIA Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. IQVIA Biologics Regulatory Affairs Outsourcing Product Portfolio Table 110. IQVIA Recent Development Table 111. Syneos Health Company Information Table 112. Syneos Health Business Overview Table 113. Syneos Health Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Syneos Health Biologics Regulatory Affairs Outsourcing Product Portfolio Table 115. Syneos Health Recent Development Table 116. SGS SA (SGS) Company Information Table 117. SGS SA (SGS) Business Overview Table 118. SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Product Portfolio Table 120. SGS SA (SGS) Recent Development Table 121. North America Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 122. North America Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 123. North America Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 124. North America Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 125. North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026) Table 127. North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2027-2032) Table 128. Europe Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 129. Europe Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 130. Europe Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 131. Europe Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 132. Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026) Table 134. Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2027-2032) Table 135. China Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 136. China Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 137. China Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 138. China Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 139. Asia Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 140. Asia Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 141. Asia Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 142. Asia Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Biologics Regulatory Affairs Outsourcing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026) Table 145. Asia Biologics Regulatory Affairs Outsourcing Market Size by Country (2027-2032) Table 146. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 147. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 148. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 149. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 150. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026) Table 152. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Biologics Regulatory Affairs Outsourcing Product Image Figure 2. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biologics Regulatory Affairs Outsourcing Market Share by Type: 2025 VS 2032 Figure 4. Regulatory Consulting Image Figure 5. Legal Representation Image Figure 6. Regulatory Writing & Publishing Image Figure 7. Product Registration Image Figure 8. Regulatory Submissions Image Figure 9. Regulatory Operations Image Figure 10. Others Image Figure 11. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 12. Global Biologics Regulatory Affairs Outsourcing Market Share by Application: 2025 VS 2032 Figure 13. Monoclonal Antibodies (mAbs) Image Figure 14. Recombinant Proteins Image Figure 15. Vaccines Image Figure 16. Cell & Gene Therapies Image Figure 17. Biosimilars Image Figure 18. Others Image Figure 19. Global Biologics Regulatory Affairs Outsourcing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 21. Global Biologics Regulatory Affairs Outsourcing Market Share by Region: 2025 VS 2032 Figure 22. Years Considered Figure 23. Global Biologics Regulatory Affairs Outsourcing Market Share by Players in 2025 Figure 24. Global Top 5 and 10 Biologics Regulatory Affairs Outsourcing Players Market Share by Revenue in 2025 Figure 25. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Biologics Regulatory Affairs Outsourcing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Type (2021-2032) Figure 28. Global Biologics Regulatory Affairs Outsourcing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Application (2021-2032) Figure 30. North America Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 31. North America Biologics Regulatory Affairs Outsourcing Market Share by Type (2021-2032) Figure 32. North America Biologics Regulatory Affairs Outsourcing Market Share by Application (2021-2032) Figure 33. North America Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032) Figure 34. United States Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 35. Canada Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 36. Mexico Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 37. Europe Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 38. Europe Biologics Regulatory Affairs Outsourcing Market Share by Type (2021-2032) Figure 39. Europe Biologics Regulatory Affairs Outsourcing Market Share by Application (2021-2032) Figure 40. Europe Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032) Figure 41. Germany Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 42. France Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 43. U.K. Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 44. Italy Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 45. Russia Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 46. Nordic Countries Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 47. China Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 48. China Biologics Regulatory Affairs Outsourcing Market Share by Type (2021-2032) Figure 49. China Biologics Regulatory Affairs Outsourcing Market Share by Application (2021-2032) Figure 50. Asia Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 51. Asia Biologics Regulatory Affairs Outsourcing Market Share by Type (2021-2032) Figure 52. Asia Biologics Regulatory Affairs Outsourcing Market Share by Application (2021-2032) Figure 53. Asia Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032) Figure 54. Japan Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 55. South Korea Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 56. Taiwan Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 57. Southeast Asia Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 58. India Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 59. Australia Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 60. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 61. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share by Type (2021-2032) Figure 62. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share by Application (2021-2032) Figure 63. South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032) Figure 64. Brazil Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 65. South Africa Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 66. Saudi Arabia Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 67. Turkey Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 68. Argentina Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 69. UAE Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 70. Egypt Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 71. Chile Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Regulatory Consulting
  • Legal Representation
  • Regulatory Writing & Publishing
  • Product Registration
  • Regulatory Submissions
  • Regulatory Operations
  • Others
Applications
  • Monoclonal Antibodies (mAbs)
  • Recombinant Proteins
  • Vaccines
  • Cell & Gene Therapies
  • Biosimilars
  • Others
Companies covered
  • Lonza AG
  • Wuxi AppTec Inc.
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific SE
  • Freyr solutions
  • Catalent Inc.
  • Piramal Group
  • AGC Biologics
  • ICON Plc.
  • Charles River Laboratories International, Inc.
  • Labcorp
  • Parexel International
  • Medpace Holdings, Inc.
  • IQVIA
  • Syneos Health
  • SGS SA (SGS)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Regulatory Consulting
  5. 1.2.3 Legal Representation
  6. 1.2.4 Regulatory Writing & Publishing
  7. 1.2.5 Product Registration
  8. 1.2.6 Regulatory Submissions
  9. 1.2.7 Regulatory Operations
  10. 1.2.8 Others
  11. 1.3 Market Analysis by Application
  12. 1.3.1 Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  13. 1.3.2 Monoclonal Antibodies (mAbs)
  14. 1.3.3 Recombinant Proteins
  15. 1.3.4 Vaccines
  16. 1.3.5 Cell & Gene Therapies
  17. 1.3.6 Biosimilars
  18. 1.3.7 Others
  19. 1.4 Global Market Growth Prospects
  20. 1.5 Global Biologics Regulatory Affairs Outsourcing Growth Trends by Region
  21. 1.5.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
  22. 1.5.2 Biologics Regulatory Affairs Outsourcing Market Size by Region (2021-2026)
  23. 1.5.3 Biologics Regulatory Affairs Outsourcing Market Size by Region (2027-2032)
  24. 1.6 Assumptions and Limitations
  25. 1.7 Study Goals and Objectives
  26. 1.8 Years Considered
2 Global Biologics Regulatory Affairs Outsourcing Market Dynamics
  1. 2.1 Biologics Regulatory Affairs Outsourcing Industry Trends
  2. 2.2 Biologics Regulatory Affairs Outsourcing Industry Drivers
  3. 2.3 Biologics Regulatory Affairs Outsourcing Industry Opportunities and Challenges
  4. 2.4 Biologics Regulatory Affairs Outsourcing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biologics Regulatory Affairs Outsourcing Revenue by Company (2021-2026)
  2. 3.2 Global Biologics Regulatory Affairs Outsourcing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biologics Regulatory Affairs Outsourcing Key Company Head office and Area Served
  4. 3.4 Global Biologics Regulatory Affairs Outsourcing Company, Product Type & Application
  5. 3.5 Global Biologics Regulatory Affairs Outsourcing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biologics Regulatory Affairs Outsourcing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biologics Regulatory Affairs Outsourcing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biologics Regulatory Affairs Outsourcing Tier 1, Tier 2, and Tier 3
4 Biologics Regulatory Affairs Outsourcing Market by Type
  1. 4.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2032)
  3. 4.3 Global Biologics Regulatory Affairs Outsourcing Market Size Share by Type (2021-2032)
5 Biologics Regulatory Affairs Outsourcing Market by Application
  1. 5.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2032)
  3. 5.3 Global Biologics Regulatory Affairs Outsourcing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Lonza AG
  2. 6.1.1 Lonza AG Company Information
  3. 6.1.2 Lonza AG Business Overview
  4. 6.1.3 Lonza AG Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Lonza AG Biologics Regulatory Affairs Outsourcing Product Portfolio
  6. 6.1.5 Lonza AG Recent Developments
  7. 6.2 Wuxi AppTec Inc.
  8. 6.2.1 Wuxi AppTec Inc. Company Information
  9. 6.2.2 Wuxi AppTec Inc. Business Overview
  10. 6.2.3 Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  12. 6.2.5 Wuxi AppTec Inc. Recent Developments
  13. 6.3 Thermo Fisher Scientific Inc.
  14. 6.3.1 Thermo Fisher Scientific Inc. Company Information
  15. 6.3.2 Thermo Fisher Scientific Inc. Business Overview
  16. 6.3.3 Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  18. 6.3.5 Thermo Fisher Scientific Inc. Recent Developments
  19. 6.4 Eurofins Scientific SE
  20. 6.4.1 Eurofins Scientific SE Company Information
  21. 6.4.2 Eurofins Scientific SE Business Overview
  22. 6.4.3 Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Product Portfolio
  24. 6.4.5 Eurofins Scientific SE Recent Developments
  25. 6.5 Freyr solutions
  26. 6.5.1 Freyr solutions Company Information
  27. 6.5.2 Freyr solutions Business Overview
  28. 6.5.3 Freyr solutions Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Freyr solutions Biologics Regulatory Affairs Outsourcing Product Portfolio
  30. 6.5.5 Freyr solutions Recent Developments
  31. 6.6 Catalent Inc.
  32. 6.6.1 Catalent Inc. Company Information
  33. 6.6.2 Catalent Inc. Business Overview
  34. 6.6.3 Catalent Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Catalent Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  36. 6.6.5 Catalent Inc. Recent Developments
  37. 6.7 Piramal Group
  38. 6.7.1 Piramal Group Company Information
  39. 6.7.2 Piramal Group Business Overview
  40. 6.7.3 Piramal Group Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Piramal Group Biologics Regulatory Affairs Outsourcing Product Portfolio
  42. 6.7.5 Piramal Group Recent Developments
  43. 6.8 AGC Biologics
  44. 6.8.1 AGC Biologics Company Information
  45. 6.8.2 AGC Biologics Business Overview
  46. 6.8.3 AGC Biologics Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 AGC Biologics Biologics Regulatory Affairs Outsourcing Product Portfolio
  48. 6.8.5 AGC Biologics Recent Developments
  49. 6.9 ICON Plc.
  50. 6.9.1 ICON Plc. Company Information
  51. 6.9.2 ICON Plc. Business Overview
  52. 6.9.3 ICON Plc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 ICON Plc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  54. 6.9.5 ICON Plc. Recent Developments
  55. 6.10 Charles River Laboratories International, Inc.
  56. 6.10.1 Charles River Laboratories International, Inc. Company Information
  57. 6.10.2 Charles River Laboratories International, Inc. Business Overview
  58. 6.10.3 Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  60. 6.10.5 Charles River Laboratories International, Inc. Recent Developments
  61. 6.11 Labcorp
  62. 6.11.1 Labcorp Company Information
  63. 6.11.2 Labcorp Business Overview
  64. 6.11.3 Labcorp Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Labcorp Biologics Regulatory Affairs Outsourcing Product Portfolio
  66. 6.11.5 Labcorp Recent Developments
  67. 6.12 Parexel International
  68. 6.12.1 Parexel International Company Information
  69. 6.12.2 Parexel International Business Overview
  70. 6.12.3 Parexel International Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Parexel International Biologics Regulatory Affairs Outsourcing Product Portfolio
  72. 6.12.5 Parexel International Recent Developments
  73. 6.13 Medpace Holdings, Inc.
  74. 6.13.1 Medpace Holdings, Inc. Company Information
  75. 6.13.2 Medpace Holdings, Inc. Business Overview
  76. 6.13.3 Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  78. 6.13.5 Medpace Holdings, Inc. Recent Developments
  79. 6.14 IQVIA
  80. 6.14.1 IQVIA Company Information
  81. 6.14.2 IQVIA Business Overview
  82. 6.14.3 IQVIA Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 IQVIA Biologics Regulatory Affairs Outsourcing Product Portfolio
  84. 6.14.5 IQVIA Recent Developments
  85. 6.15 Syneos Health
  86. 6.15.1 Syneos Health Company Information
  87. 6.15.2 Syneos Health Business Overview
  88. 6.15.3 Syneos Health Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Syneos Health Biologics Regulatory Affairs Outsourcing Product Portfolio
  90. 6.15.5 Syneos Health Recent Developments
  91. 6.16 SGS SA (SGS)
  92. 6.16.1 SGS SA (SGS) Company Information
  93. 6.16.2 SGS SA (SGS) Business Overview
  94. 6.16.3 SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Product Portfolio
  96. 6.16.5 SGS SA (SGS) Recent Developments
7 North America
  1. 7.1 North America Biologics Regulatory Affairs Outsourcing Market Size (2021-2032)
  2. 7.2 North America Biologics Regulatory Affairs Outsourcing Market Size by Type
  3. 7.2.1 North America Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026)
  4. 7.2.2 North America Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032)
  5. 7.2.3 North America Biologics Regulatory Affairs Outsourcing Market Share by Type (2021-2032)
  6. 7.3 North America Biologics Regulatory Affairs Outsourcing Market Size by Application
  7. 7.3.1 North America Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026)
  8. 7.3.2 North America Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032)
  9. 7.3.3 North America Biologics Regulatory Affairs Outsourcing Market Share by Application (2021-2032)
  10. 7.4 North America Biologics Regulatory Affairs Outsourcing Market Size by Country
  11. 7.4.1 North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026)
  13. 7.4.3 North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2027-2032)
  14. 7.4.4 North America Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biologics Regulatory Affairs Outsourcing Market Size (2021-2032)
  2. 8.2 Europe Biologics Regulatory Affairs Outsourcing Market Size by Type
  3. 8.2.1 Europe Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biologics Regulatory Affairs Outsourcing Market Share by Type (2021-2032)
  6. 8.3 Europe Biologics Regulatory Affairs Outsourcing Market Size by Application
  7. 8.3.1 Europe Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biologics Regulatory Affairs Outsourcing Market Share by Application (2021-2032)
  10. 8.4 Europe Biologics Regulatory Affairs Outsourcing Market Size by Country
  11. 8.4.1 Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biologics Regulatory Affairs Outsourcing Market Size (2021-2032)
  2. 9.2 China Biologics Regulatory Affairs Outsourcing Market Size by Type
  3. 9.2.1 China Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026)
  4. 9.2.2 China Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032)
  5. 9.2.3 China Biologics Regulatory Affairs Outsourcing Market Share by Type (2021-2032)
  6. 9.3 China Biologics Regulatory Affairs Outsourcing Market Size by Application
  7. 9.3.1 China Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026)
  8. 9.3.2 China Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032)
  9. 9.3.3 China Biologics Regulatory Affairs Outsourcing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biologics Regulatory Affairs Outsourcing Market Size (2021-2032)
  2. 10.2 Asia Biologics Regulatory Affairs Outsourcing Market Size by Type
  3. 10.2.1 Asia Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biologics Regulatory Affairs Outsourcing Market Share by Type (2021-2032)
  6. 10.3 Asia Biologics Regulatory Affairs Outsourcing Market Size by Application
  7. 10.3.1 Asia Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biologics Regulatory Affairs Outsourcing Market Share by Application (2021-2032)
  10. 10.4 Asia Biologics Regulatory Affairs Outsourcing Market Size by Country
  11. 10.4.1 Asia Biologics Regulatory Affairs Outsourcing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biologics Regulatory Affairs Outsourcing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst